Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%

NCT04329403 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Market reasons

Conditions

Acne Vulgaris

Interventions

DRUG: Adapalene 0.1% Gel
DRUG: Differin 0.1% Topical Gel
OTHER: Placebo

Sponsor

Aurobindo Pharma Ltd